Benefit weighting by the five stakeholder groups
Benefit weighting group mean values (range) | ||||||
---|---|---|---|---|---|---|
Benefit criteria | Directors of public health (n=10) | Scottish General Medical Services Committee (n=10) | Scottish Cardiac Society (n=4) | Scottish Association of Health Councils (n=4) | Scottish Office CHD priority team (n=1) | Between group mean |
Hospital activity | 7.2 (0 to 10) | 7.70 (3 to 12) | 10.50 (3 to 19) | 8.75 (5 to 20) | 5 | 7.83 |
Primary care activity | 7.00 (0 to 10) | 10.50 (3 to 20) | 9.50 (4 to 19) | 11.25 (5 to 20) | 8 | 9.25 |
Prescribing | 4.00 (0 to 6) | 8.10 (4 to 12) | 5.75 (2 to 10) | 5.75 (3 to 10) | 5 | 5.72 |
Socioeconomic impact | 4.10 (0 to 7) | 4.70 (1 to 8) | 3.75 (1 to 5) | 5.50 (0 to 15) | 2 | 4.01 |
Risk factors | 7.70 (0 to 10) | 9.10 (5 to 14) | 6.25 (4 to 10) | 3.75 (0 to 10) | 10 | 7.36 |
Prevalence | 9.40 (5 to 25) | 6.90 (2 to 11) | 5.75 (2 to 10) | 3.00 (0 to 5) | 0 | 5.01 |
Incidence | 9.30 (5 to 25) | 6.40 (3 to 11) | 5.00 (2 to 8) | 9.50 (5 to 20) | 0 | 6.04 |
Case registration | 4.10 (0 to 6) | 5.50 (3 to 10) | 5.00 (2 to 10) | 9.50 (5 to 20) | 10 | 6.82 |
Mortality rates and case fatality | 11.70 (5 to 20) | 11.40 (6 to 25) | 13.25 (8 to 20) | 6.50 (0 to 10) | 10 | 10.57 |
Patient function | 10.55 (5 to 20) | 8.00 (4 to 12) | 12.25 (5 to 30) | 8.00 (0 to 20) | 5 | 8.76 |
Quality of life | 10.65 (5 to 20) | 6.30 (2 to 10) | 11.50 (5 to 30) | 15.50 (5 to 30) | 5 | 9.79 |
Compatibility for international comparisons | 5.60 (0 to 10) | 4.80 (2 to 10) | 4.25 (3 to 5) | 1.25 (0 to 3) | 5 | 4.18 |
Breadth of coverage | 4.35 (0 to 10) | 6.60 (4 to 12) | 4.25 (0 to 10) | 9.00 (3 to 15) | 20 | 8.84 |
Frequency | 4.35 (0 to 10) | 4.00 (2 to 5) | 3.00 (1 to 5) | 2.75 (1 to 5) | 15 | 5.82 |